These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
309 related articles for article (PubMed ID: 29900893)
1. Heinrichs MT; May RJ; Heider F; Reimers T; B Sy SK; Peloquin CA; Derendorf H Int J Mycobacteriol; 2018; 7(2):156-161. PubMed ID: 29900893 [TBL] [Abstract][Full Text] [Related]
2. In vitro activity of (-)-deoxypergularinine, on its own and in combination with anti-tubercular drugs, against resistant strains of Mycobacterium tuberculosis. Nam KW; Jang WS; Jyoti MA; Kim S; Lee BE; Song HY Phytomedicine; 2016 May; 23(5):578-82. PubMed ID: 27064017 [TBL] [Abstract][Full Text] [Related]
3. Comparative proteomic analysis of Mycobacterium tuberculosis strain H37Rv versus H37Ra. Jena L; Kashikar S; Kumar S; Harinath BC Int J Mycobacteriol; 2013 Dec; 2(4):220-6. PubMed ID: 26786126 [TBL] [Abstract][Full Text] [Related]
4. Meropenem-clavulanate has high in vitro activity against multidrug-resistant Mycobacterium tuberculosis. Davies Forsman L; Giske CG; Bruchfeld J; Schön T; Juréen P; Ängeby K Int J Mycobacteriol; 2015 Mar; 4 Suppl 1():80-1. PubMed ID: 27128620 [TBL] [Abstract][Full Text] [Related]
5. Activity of rifampicin and linezolid combination in Mycobacterium tuberculosis. Maltempe FG; Caleffi-Ferracioli KR; do Amaral RCR; de Oliveira Demitto F; Siqueira VLD; de Lima Scodro RB; Hirata MH; Pavan FR; Cardoso RF Tuberculosis (Edinb); 2017 May; 104():24-29. PubMed ID: 28454646 [TBL] [Abstract][Full Text] [Related]
6. The Effect of Combining Natural Terpenes and Antituberculous Agents against Reference and Clinical Mycobacterium tuberculosis Strains. Sieniawska E; Sawicki R; Swatko-Ossor M; Napiorkowska A; Przekora A; Ginalska G; Augustynowicz-Kopec E Molecules; 2018 Jan; 23(1):. PubMed ID: 29342972 [No Abstract] [Full Text] [Related]
8. Cubosome Lipid Nanocarriers As a Drug Delivery Vehicle for Intracellular Sarkar S; Dyett B; Lakic B; Ball AS; Yeo LY; White JF; Soni S; Drummond CJ; Conn CE ACS Appl Mater Interfaces; 2023 May; 15(18):21819-21829. PubMed ID: 37018059 [No Abstract] [Full Text] [Related]
9. Discovery of novel 5-(ethyl or hydroxymethyl) analogs of 2'-'up' fluoro (or hydroxyl) pyrimidine nucleosides as a new class of Mycobacterium tuberculosis, Mycobacterium bovis and Mycobacterium avium inhibitors. Shakya N; Srivastav NC; Bhavanam S; Tse C; Desroches N; Agrawal B; Kunimoto DY; Kumar R Bioorg Med Chem; 2012 Jul; 20(13):4088-97. PubMed ID: 22664188 [TBL] [Abstract][Full Text] [Related]
10. [Induction in vitro and stability of Mycobacterium tuberculosis resistance to ofloxacin]. Yang H; Hu Z; Sha W; Lu J; Cui Z; Wang J; Huang X; Xiao H Zhonghua Yu Fang Yi Xue Za Zhi; 2014 Apr; 48(4):318-23. PubMed ID: 24969458 [TBL] [Abstract][Full Text] [Related]
11. Microplate alamar blue assay versus BACTEC 460 system for high-throughput screening of compounds against Mycobacterium tuberculosis and Mycobacterium avium. Collins L; Franzblau SG Antimicrob Agents Chemother; 1997 May; 41(5):1004-9. PubMed ID: 9145860 [TBL] [Abstract][Full Text] [Related]
12. Antimycobacterial activity of medicinal plants used by the Mayo people of Sonora, Mexico. Coronado-Aceves EW; Sánchez-Escalante JJ; López-Cervantes J; Robles-Zepeda RE; Velázquez C; Sánchez-Machado DI; Garibay-Escobar A J Ethnopharmacol; 2016 Aug; 190():106-15. PubMed ID: 27262564 [TBL] [Abstract][Full Text] [Related]
13. Effect of single amino acid mutations on function of Mycobacterium tuberculosis H37RV and H37RA by computational approaches. Jena L; Kashikar S; Kumar S; Harinath BC Indian J Tuberc; 2014 Jul; 61(3):200-6. PubMed ID: 25241568 [TBL] [Abstract][Full Text] [Related]
14. [Determination of in vitro synergy by a checkerboard method when 3 core antimicrobial agents of the retreatment new scheme combined against MDR-MTB and XDR-MTB]. Zhang LL; Yang H; Xiao HP; Lu JM; Sha W; Zhang Q Zhonghua Jie He He Hu Xi Za Zhi; 2016 Jun; 39(6):464-8. PubMed ID: 27289577 [TBL] [Abstract][Full Text] [Related]
15. Anti-mycobacterial activity of some medicinal plants used traditionally by tribes from Madhya Pradesh, India for treating tuberculosis related symptoms. Gupta VK; Kaushik A; Chauhan DS; Ahirwar RK; Sharma S; Bisht D J Ethnopharmacol; 2018 Dec; 227():113-120. PubMed ID: 30172059 [TBL] [Abstract][Full Text] [Related]
16. Comparison of the E test and a proportion dilution method for susceptibility testing of Mycobacterium tuberculosis. Fabry W; Schmid EN; Ansorg R Zentralbl Bakteriol; 1995 Oct; 282(4):394-401. PubMed ID: 9810662 [TBL] [Abstract][Full Text] [Related]
17. Antimycobacterial activity of Citrullus colocynthis (L.) Schrad. against drug sensitive and drug resistant Mycobacterium tuberculosis and MOTT clinical isolates. Mehta A; Srivastva G; Kachhwaha S; Sharma M; Kothari SL J Ethnopharmacol; 2013 Aug; 149(1):195-200. PubMed ID: 23816500 [TBL] [Abstract][Full Text] [Related]
18. In vitro antimycobacterial activity of 2-(((2-hydroxyphenyl)amino)methylene)-5,5-dimethylcyclohexane-1,3-dione: a new chemical entity against Mycobacterium tuberculosis. Rather MA; Bhat ZS; Lone AM; Maqbool M; Amin S; Bhat BA; Ahmad Z Int J Antimicrob Agents; 2018 Aug; 52(2):265-268. PubMed ID: 29510188 [TBL] [Abstract][Full Text] [Related]
19. In vitro and in vivo activity of biapenem against drug-susceptible and rifampicin-resistant Mycobacterium tuberculosis. Kaushik A; Ammerman NC; Tasneen R; Story-Roller E; Dooley KE; Dorman SE; Nuermberger EL; Lamichhane G J Antimicrob Chemother; 2017 Aug; 72(8):2320-2325. PubMed ID: 28575382 [TBL] [Abstract][Full Text] [Related]
20. 3'-bromo analogues of pyrimidine nucleosides as a new class of potent inhibitors of Mycobacterium tuberculosis. Shakya N; Srivastav NC; Desroches N; Agrawal B; Kunimoto DY; Kumar R J Med Chem; 2010 May; 53(10):4130-40. PubMed ID: 20420370 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]